The current gold standard for laryngeal cancer diagnosis is either physical exam of throat and neck, a biopsy of the throat, or medical imaging , all of which are relatively expensive and are inaccessible for many areas of the world. Moreover, these forms of diagnosis are more invasive and have a high propensity of false negative results. That is why most diagnoses of laryngeal cancer are made in the late stages of the disease, which makes it very difficult to cure. The late-stage disease is associated with worse outcomes, warrants multimodal therapy, and is less likely to allow for the preservation of the larynx . Non-cancerous voice box diseases, such as laryngitis, voice box paralysis, and vocal leukoplakia, can also cause similar symptoms and may be misdiagnosed as laryngeal cancer . However, the early detection of laryngeal cancer significantly increases survival rate and reduces the length of hospital stay and health care costs for patients . Thus, the need for a reliable and accurate diagnosis method exists and can serve as a potential solution for decreasing laryngeal cancer mortality rates.